Quest Diagnostics Incorporated (DGX)
NYSE: DGX · Real-Time Price · USD
182.51
-1.67 (-0.91%)
Dec 5, 2025, 4:00 PM EST - Market closed
Quest Diagnostics Market Cap
Quest Diagnostics has a market cap or net worth of $20.30 billion as of December 5, 2025. Its market cap has increased by 12.21% in one year.
Market Cap
20.30B
Enterprise Value
26.25B
1-Year Change
12.21%
Ranking
Category
Stock Price
$182.51
Market Cap Chart
Since December 1, 1998, Quest Diagnostics's market cap has increased from $531.80M to $20.30B, an increase of 3,717.76%. That is a compound annual growth rate of 14.43%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Dec 4, 2025 | 20.49B | 21.68% |
| Dec 31, 2024 | 16.84B | 8.62% |
| Dec 29, 2023 | 15.50B | -12.99% |
| Dec 30, 2022 | 17.82B | -16.05% |
| Dec 31, 2021 | 21.22B | 32.15% |
| Dec 31, 2020 | 16.06B | 11.65% |
| Dec 31, 2019 | 14.38B | 26.95% |
| Dec 31, 2018 | 11.33B | -15.59% |
| Dec 29, 2017 | 13.42B | 5.36% |
| Dec 30, 2016 | 12.74B | 24.94% |
| Dec 31, 2015 | 10.20B | 5.21% |
| Dec 31, 2014 | 9.69B | 24.48% |
| Dec 31, 2013 | 7.79B | -15.94% |
| Dec 31, 2012 | 9.26B | 1.13% |
| Dec 30, 2011 | 9.16B | -0.41% |
| Dec 31, 2010 | 9.20B | -17.62% |
| Dec 31, 2009 | 11.16B | 9.95% |
| Dec 31, 2008 | 10.15B | -0.86% |
| Dec 31, 2007 | 10.24B | -0.93% |
| Dec 29, 2006 | 10.34B | -0.63% |
| Dec 30, 2005 | 10.40B | 7.59% |
| Dec 31, 2004 | 9.67B | 27.23% |
| Dec 31, 2003 | 7.60B | 36.58% |
| Dec 31, 2002 | 5.56B | -18.81% |
| Dec 31, 2001 | 6.85B | 4.46% |
View and export this data all the way back to 1998.
Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 925.43B |
| Johnson & Johnson | 494.70B |
| AbbVie | 406.92B |
| UnitedHealth Group | 307.72B |
| AstraZeneca | 283.29B |
| Novartis AG | 257.47B |
| Merck & Co. | 253.84B |
| Thermo Fisher Scientific | 218.08B |